Risks and benefits of anticancer drugs in advanced cancer patients: A systematic review and meta-analysis

Background: Randomized clinical trials (RCTs) of anticancer drugs without active comparators in patients who have exhausted standard of care treatment options are debated. We aimed to quantify the safety and the efficacy of anticancer drugs in advanced cancer patients who have exhausted standard of...

Descripción completa

Detalles Bibliográficos
Autores principales: Moreau Bachelard, Camille, Coquan, Elodie, du Rusquec, Pauline, Paoletti, Xavier, Le Tourneau, Christophe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548931/
https://www.ncbi.nlm.nih.gov/pubmed/34746718
http://dx.doi.org/10.1016/j.eclinm.2021.101130

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548931/
https://www.ncbi.nlm.nih.gov/pubmed/34746718
http://dx.doi.org/10.1016/j.eclinm.2021.101130

Ejemplares similares